Last reviewed · How we verify

NCT06564402: APEX

Augmentation of Exposure Using Positive Mental Rehearsal in Individuals With Increased Social Anxiety

Recruiting now NA Last updated 9 January 2026
What this trial tests

NA trial testing Positive Mental Rehearsal in Social Anxiety in 40 participants. Currently enrolling.

Timeline
28 May 2024
Primary endpoint
1 February 2026
1 March 2026

Quick facts

Lead sponsorPhilipps University Marburg
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment40
Start date28 May 2024
Primary completion1 February 2026
Estimated completion1 March 2026
Sites1 location across Germany

Drugs / interventions tested

Conditions studied

Sponsor

Philipps University Marburg

Who can join

18 and older, any sex, with Social Anxiety or Social Phobia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Efficacy of an optimized exposure therapy training is investigated in individuals with heightened social anxiety. Participants will undergo a one-session standardized exposure training, followed by either standard or positive mental rehearsal of the exposure experience. The efficacy is measured by symptom improvement according to subjective ratings one week later.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Social Anxiety

Currently open trials in the same condition.

Other Philipps University Marburg trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06564402.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing